The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Functional-annotation report: Drosophila melanogaster CG8841/Q0E9B5

Executive conclusion

The gene symbol “Dmc1” is ambiguous and the literature is limited for this specific protein. For the target defined here—UniProt Q0E9B5, D. melanogaster CG8841/FBgn0033713—the supplied UniProt annotation identifies a HID-1-family protein containing HID1/Ecm30 (InterPro IPR026705) and Hid1 (Pfam PF12722). It must not be confused with the well-known DMC1 meiotic recombinase. Exact searches for Q0E9B5, CG8841, and FBgn0033713 yielded no primary study directly testing this fly protein; consequently, recombinase literature was excluded.

The most defensible annotation is therefore orthology-based: CG8841 probably encodes a nonenzymatic, membrane-associated regulator of the regulated secretory pathway, acting at the Golgi/trans-Golgi network (TGN) and immature dense-core vesicles to support lumenal acidification, cargo sorting/storage, and secretory-granule maturation. Its precise function, localization, cargo dependence, and phenotype have not been demonstrated directly in Drosophila.

Table: This table separates target-specific database annotation from experiments on HID-1 orthologs and labels the resulting confidence. It highlights that the proposed secretory-vesicle function and Golgi localization remain orthology-based for Drosophila CG8841.

1. Identity and nomenclature verification

The specified organism is fruit fly, Drosophila melanogaster, and the stable target identifiers are Q0E9B5, CG8841, and FBgn0033713. The supplied family/domain assignments—HID-1 family, HID1/Ecm30, and Pfam Hid1—are internally consistent with the retrieved HID-1 literature. HID-1 is described as conserved among C. elegans, Drosophila, mouse, and human, although the papers retrieved did not explicitly map the fly homolog to CG8841; that final mapping rests on the supplied UniProt record (du2016hid1isrequired pages 1-2).

The label Dmc1 should not be used alone in literature searches or functional summaries, because it ordinarily retrieves an unrelated RecA-family meiotic DNA recombinase. Nothing retrieved for HID-1 supports ATP-dependent strand exchange, meiotic recombination, DNA binding, or another DMC1-recombinase function.

2. Protein class and primary molecular function

HID-1 is best classified as a peripheral membrane trafficking/assembly regulator, not an enzyme, transporter, receptor, or secreted cargo. No catalytic reaction, active site, transported substrate, or ligand specificity has been established. Earlier work described HID-1 as lacking recognizable conventional homology domains, notwithstanding its defining HID1-family region, and suggested reversible partitioning between membrane and cytosol (du2016hid1isrequired pages 1-2).

Across experimentally studied orthologs, HID-1 acts early in dense-core-vesicle formation rather than as an essential component of the final calcium-triggered plasma-membrane fusion machinery. In rat neuroendocrine cells, HID-1 loss reduced vesicle abundance, altered morphology and dense-core formation, impaired storage of peptide hormones and monoamines, and disrupted sorting of soluble and transmembrane regulated-secretory cargo. Calcium responsiveness and normalized exocytotic competence were comparatively preserved, pointing to deficient cargo availability and vesicle biogenesis rather than a general exocytosis block (hummer2017hid1controlsformation pages 1-2, bartsch2022hid1asa pages 25-27, bartsch2022hid1asa pages 122-124).

A proposed mechanism is that Golgi-associated HID-1 helps retain or position the V-ATPase a2 subunit ATP6V0A2, thereby sustaining the acidic TGN lumen required for cargo aggregation and sorting. HID-1 knockout caused strong ATP6V0A2 redistribution without a major reduction in total protein. This is a plausible cell-biological model, but a direct physical interaction and the description of HID-1 as an ATP6V0A2 “anchor” remain incompletely proven (bartsch2022hid1asa pages 124-127, bartsch2022hid1asa pages 117-119).

A complementary mouse β-cell study placed HID-1 in homotypic fusion of immature secretory granules. Conditional loss caused accumulation of immature granules, defective proinsulin processing, an elevated serum proinsulin/insulin ratio, insufficient insulin release, and glucose intolerance. Thus, the literature supports several connected early-stage activities—TGN cargo sorting and acidification, granule budding/formation, and immature-granule fusion—rather than one demonstrated catalytic step (du2016hid1isrequired pages 1-2).

Functional annotation proposed for CG8841

Putative regulator of dense-core secretory-vesicle biogenesis and maturation at the Golgi/TGN; likely promotes appropriate organelle acidification, regulated-secretory cargo sorting/storage, and maturation of immature granules.

This annotation has moderate confidence by conserved-family inference, but it remains unvalidated in fruit fly.

3. Cellular localization

The predicted functional site is the cytosolic face of the medial/trans-Golgi and TGN, with possible association with immature dense-core-vesicle or precursor membranes.

In C. elegans, neuronal HID-1–GFP was membrane-associated and appeared in puncta in the nerve ring and dorsal cord. Its delivery toward synaptic regions required the UNC-104 kinesin. Substitution of the conserved second-position glycine with asparagine produced diffuse/mislocalized protein, shifted part of it into the soluble fraction, and abolished functional rescue, supporting N-terminal glycine-dependent—probably myristoylation-dependent—membrane attachment (mesa2011hid1anew pages 6-7, mesa2011hid1anew pages 7-9, mesa2011hid1anew pages 1-2).

In PC12 cells, murine HID-1 was enriched near the TGN and partially colocalized with Syntaxin-6 and CI-M6PR, with little association with cis/medial Golgi, early endosomes, or lysosomes. Partial overlap with Rab27, synaptotagmin I, and perinuclear neuropeptide Y was also observed (mesa2011hid1anew pages 17-21). Later human-cell work found endogenous HID1 mainly in cytosolic fractions, with smaller membrane/cytoskeletal pools and only faint nuclear signal; imperfect fraction purity and model-dependent localization limit fine compartment assignments (bartsch2022hid1asa pages 80-84).

Accordingly, CG8841 should not yet receive an experimentally verified fly Golgi annotation. Golgi/TGN and secretory-vesicle localization are predictions transferred from orthologs.

4. Biological process and pathway placement

The inferred pathway is:

TGN acidification and cargo aggregation → regulated-secretory cargo sorting/retention → dense-core-vesicle budding/biogenesis → homotypic fusion and maturation of immature granules → storage and stimulus-dependent secretion of neuropeptides, peptide hormones, and monoamines.

Direct C. elegans genetics place HID-1 in peptidergic signaling. Null mutants had reduced endogenous neuropeptide levels and altered secretion of neuronal and intestinal dense-core-vesicle cargo, with neuromuscular, defecation, and dauer-related phenotypes. Genetic relationships with peptide-processing pathways and parallel behavior relative to RAB-3/RAB-27 further support action in neurosecretory trafficking rather than classical synaptic-vesicle transmission alone (mesa2011hid1anew pages 7-9, mesa2011hid1anew pages 6-7, mesa2011hid1anew pages 1-2).

This pathway assignment does not establish which fly neuropeptides or endocrine tissues depend on CG8841. Those are important unresolved questions.

5. Quantitative evidence from ortholog systems

• In C. elegans, axonal HID-1–GFP punctate fluorescence increased approximately 80% in unc-31/CAPS mutants and 160% in unc-13 mutants, consistent with accumulation on exocytic vesicles or precursors when priming/secretion is disrupted (mesa2011hid1anew pages 7-9).
• In HID-1-deficient PC12 cells, secretogranin II was reduced to approximately 40% of wild-type, despite no corresponding decrease in Scg2 transcription; lysosomal degradation accounted for part of the loss (bartsch2022hid1asa pages 25-27).
• Human SH-SY5Y HID1-edited lines showed SGII protein at approximately 13 ± 3.3% to 46 ± 15% of wild-type, accompanied by loss of dispersed CHGA-positive puncta and perinuclear retention (bartsch2022hid1asa pages 124-127).
• Human-cell affinity proteomics identified at least 66 candidate wild-type HID1 interactors; 63 were not enriched with the p.G320Rfs*3 truncation model, while three were shared. These are candidate complex associations, not necessarily direct binding partners (bartsch2022hid1asa pages 119-122).
• During SH-SY5Y differentiation, HID1 mRNA approximately doubled and protein increased about fivefold. HID1-deficient lines had impaired neurite morphology, abnormal differentiation-marker responses, and clone-dependent apoptosis (bartsch2022hid1asa pages 127-129).

These values demonstrate conserved biological importance but cannot be reported as measurements of fly CG8841.

6. Recent developments and current research status

No substantive 2023–2024 primary publication directly addressing CG8841/Q0E9B5 was identified. A 2024 Drosophila secretory-granule thesis was retrieved, but the available material did not provide direct CG8841 evidence. Thus, the request to prioritize 2023–2024 evidence cannot be met without substituting unrelated genes or overinterpreting general secretory-granule work.

The most recent detailed HID1 investigation retrieved was a 2022 doctoral study using human SH-SY5Y and HeLa models. It expanded the candidate interactome, modeled a pathogenic p.G320Rfs*3 allele, and linked HID1 loss to defective neuronal differentiation and secretory-vesicle phenotypes. The premature-stop transcript underwent nonsense-mediated decay in edited SH-SY5Y cells; candidate interactors included VGF, TM9SF3, dynein-related machinery, ARF proteins, and VPS35, but direct interactions and their physiological relevance remain unresolved (bartsch2022hid1asa pages 131-134, bartsch2022hid1asa pages 119-122, bartsch2022hid1asa pages 117-119).

The field’s current expert-level interpretation is therefore cautious: HID1 is convincingly connected to Golgi/dense-core-vesicle biology, but whether its primary biochemical role is V-ATPase positioning, cargo selection, vesicle budding, transport coupling, immature-granule fusion, or coordination of several of these processes remains unsettled.

7. Applications and real-world relevance

There is no current fly-specific biotechnology, therapeutic, diagnostic, or agricultural implementation for CG8841. Its principal application is as a comparative model candidate for studying regulated secretion.

Ortholog research shows relevance to pancreatic β-cell biology, because mouse HID-1 loss disrupts proinsulin processing and glucose homeostasis (du2016hid1isrequired pages 1-2). Human loss-of-function studies connect HID1 to severe early-onset neurodevelopmental disease and motivate cellular assays of neuronal differentiation, survival, and dense-core-vesicle trafficking; however, these disease findings concern human HID1 and should not be directly assigned as CG8841 phenotypes (bartsch2022hid1asa pages 106-114, bartsch2022hid1asa pages 131-134).

8. Evidence gaps and recommended validation

The following experiments would convert the annotation from inference to direct fly evidence:

1. Endogenous CG8841 tagging and colocalization with cis-/trans-Golgi, TGN, and dense-core-vesicle markers.
2. CG8841-null or tissue-specific knockdown experiments in peptidergic neurons and endocrine cells, accompanied by genomic rescue.
3. Quantification of TGN pH, V-ATPase localization, secretory-granule number and morphology, and stimulus-dependent neuropeptide release.
4. Mutation of the predicted N-terminal membrane-targeting glycine to test whether fly CG8841 uses the conserved myristoylation mechanism.
5. Proximity labeling or affinity purification to test ATP6V0A2, ARF-family, dynein, VGF-like cargo, and granule-maturation machinery, followed by direct-binding validation.
6. Structural and biochemical work to determine whether the HID1/Ecm30 region is a scaffold, lipid-binding module, or regulator of another membrane protein.

9. Overall assessment

High confidence: Q0E9B5/CG8841 is the intended D. melanogaster HID-1-family protein and is not the canonical DMC1 meiotic recombinase.

Moderate confidence: conserved-family evidence predicts a role at the Golgi/TGN in dense-core-vesicle biogenesis, cargo handling, acidification, and maturation.

Low confidence/unresolved: exact fly localization, tissues, cargoes, interaction partners, organismal phenotypes, and molecular mechanism. No catalytic reaction or substrate specificity is currently established.

Key literature

• Mesa R. et al. “HID-1, a New Component of the Peptidergic Signaling Pathway.” Genetics 187, 467–483. Published February 2011. https://doi.org/10.1534/genetics.110.121996 (mesa2011hid1anew pages 1-2)
• Du W. et al. “HID-1 is required for homotypic fusion of immature secretory granules during maturation.” eLife 5. Published October 2016. https://doi.org/10.7554/eLife.18134 (du2016hid1isrequired pages 1-2)
• Hummer B.H. et al. “HID-1 controls formation of large dense core vesicles by influencing cargo sorting and trans-Golgi network acidification.” Molecular Biology of the Cell 28, 3870–3880. Published December 2017. https://doi.org/10.1091/mbc.e17-08-0491 (hummer2017hid1controlsformation pages 1-2)
• Bartsch L.M. “HID1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies.” Doctoral dissertation. Published 2022. https://doi.org/10.53846/goediss-9438 (bartsch2022hid1asa pages 80-84)

References

1. (du2016hid1isrequired pages 1-2): Wen Du, Maoge Zhou, Wei Zhao, Dongwan Cheng, Lifen Wang, Jingze Lu, Eli Song, Wei Feng, Yanhong Xue, Pingyong Xu, and Tao Xu. Hid-1 is required for homotypic fusion of immature secretory granules during maturation. eLife, Oct 2016. URL: https://doi.org/10.7554/elife.18134, doi:10.7554/elife.18134. This article has 55 citations and is from a domain leading peer-reviewed journal.

2. (bartsch2022hid1asa pages 119-122): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

3. (hummer2017hid1controlsformation pages 1-2): Blake H. Hummer, Noah F. de Leeuw, Christian Burns, Lan Chen, Matthew S. Joens, Bethany Hosford, James A. J. Fitzpatrick, and Cedric S. Asensio. Hid-1 controls formation of large dense core vesicles by influencing cargo sorting and trans-golgi network acidification. Molecular Biology of the Cell, 28:3870-3880, Dec 2017. URL: https://doi.org/10.1091/mbc.e17-08-0491, doi:10.1091/mbc.e17-08-0491. This article has 49 citations and is from a domain leading peer-reviewed journal.

4. (mesa2011hid1anew pages 6-7): Rosana Mesa, Shuo Luo, Christopher M Hoover, Kenneth Miller, Alicia Minniti, Nibaldo Inestrosa, and Michael L Nonet. Hid-1, a new component of the peptidergic signaling pathway. Genetics, 187:467-483, Feb 2011. URL: https://doi.org/10.1534/genetics.110.121996, doi:10.1534/genetics.110.121996. This article has 36 citations and is from a domain leading peer-reviewed journal.

5. (mesa2011hid1anew pages 17-21): Rosana Mesa, Shuo Luo, Christopher M Hoover, Kenneth Miller, Alicia Minniti, Nibaldo Inestrosa, and Michael L Nonet. Hid-1, a new component of the peptidergic signaling pathway. Genetics, 187:467-483, Feb 2011. URL: https://doi.org/10.1534/genetics.110.121996, doi:10.1534/genetics.110.121996. This article has 36 citations and is from a domain leading peer-reviewed journal.

6. (bartsch2022hid1asa pages 80-84): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

7. (mesa2011hid1anew pages 1-2): Rosana Mesa, Shuo Luo, Christopher M Hoover, Kenneth Miller, Alicia Minniti, Nibaldo Inestrosa, and Michael L Nonet. Hid-1, a new component of the peptidergic signaling pathway. Genetics, 187:467-483, Feb 2011. URL: https://doi.org/10.1534/genetics.110.121996, doi:10.1534/genetics.110.121996. This article has 36 citations and is from a domain leading peer-reviewed journal.

8. (bartsch2022hid1asa pages 124-127): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

9. (bartsch2022hid1asa pages 117-119): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

10. (mesa2011hid1anew pages 7-9): Rosana Mesa, Shuo Luo, Christopher M Hoover, Kenneth Miller, Alicia Minniti, Nibaldo Inestrosa, and Michael L Nonet. Hid-1, a new component of the peptidergic signaling pathway. Genetics, 187:467-483, Feb 2011. URL: https://doi.org/10.1534/genetics.110.121996, doi:10.1534/genetics.110.121996. This article has 36 citations and is from a domain leading peer-reviewed journal.

11. (bartsch2022hid1asa pages 25-27): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

12. (bartsch2022hid1asa pages 122-124): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

13. (bartsch2022hid1asa pages 127-129): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

14. (bartsch2022hid1asa pages 131-134): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

15. (bartsch2022hid1asa pages 106-114): Lydia Maximiliane Bartsch. Hid1 as a novel disease-causing gene in early onset neurological disorders: molecular, functional and phenotypic studies. ArXiv, 2022. URL: https://doi.org/10.53846/goediss-9438, doi:10.53846/goediss-9438. This article has 1 citations.

Artifacts

• Edison artifact artifact-00

Citations

1. https://doi.org/10.1534/genetics.110.121996
2. https://doi.org/10.7554/eLife.18134
3. https://doi.org/10.1091/mbc.e17-08-0491
4. https://doi.org/10.53846/goediss-9438
5. https://doi.org/10.7554/elife.18134,
6. https://doi.org/10.53846/goediss-9438,
7. https://doi.org/10.1091/mbc.e17-08-0491,
8. https://doi.org/10.1534/genetics.110.121996,